©The Author(s) 2019.
World J Gastroenterol. Oct 14, 2019; 25(38): 5732-5772
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5732
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5732
Table 5 Zinc transporters
| Gene name | Cancer | Role | Functional activity |
| ZnT1/SLC30A1 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
| ZnT2/SLC30A2 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
| ZnT3/SLC30A3 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
| ZnT4/SLC30A4 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
| ZnT5/SLC30A5 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
| ZnT6/SLC30A6 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
| ZnT7/SLC30A7 | Esophageal colorectal | Oncogene oncogene | Increased mRNA expression in tumors[308,335] Increased mRNA expression in tumors[337] |
| ZnT8/SLC30A8 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
| ZnT9/SLC30A9 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
| ZIP1/SLC39A1 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
| Pancreatic | Tumor suppressor | Down regulated mRNA expression in tumors[313] | |
| ZIP2/SLC39A2 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
| Pancreatic | Tumor suppressor | mRNA expression down-regulated in tumors[313] | |
| ZIP3/SLC39A3 | Pancreatic | Tumor suppressor | Decreased expression in adenocarcinoma[308,313,331,343] |
| Oncogene | Medium to high mRNA expression in multiple human PC cell lines[313] | ||
| ZIP4/SLC39A4 | Hepatocellular | Oncogene | Increased mRNA and protein expression, repressed apoptosis, enhanced cell cycle and migration[308,325,344-346] |
| Pancreatic | Oncogene | Increased expression in PDAC and PC cell lines, link to CREB-miR-373 axis, promotes cancer xenograft growth in nude mice[313,325-327] | |
| Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
| ZIP5/SLC39A5 | Esophageal | Oncogene | Increased expression in ESCC, knockdown in cell lines inhibited migration and invasion[308,334] |
| Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
| Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
| ZIP6/LIV-1/SLC39A6 | Pancreatic | Oncogene | Increased expression in tumors and cell lines[313,330] |
| Tumor suppressor | Decreased mRNA expression in tumors[313] | ||
| Hepatocellular | Oncogene | Increased mRNA and protein expression[308,347] | |
| Esophageal | Oncogene | Increased expression in ESCC[308,333] | |
| Colorectal | Oncogene | Increased mRNA expression in tumors[337] | |
| Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
| ZIP7/SLC39A7 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
| Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
| Colorectal | Oncogene | Increased mRNA expression in tumors and CRC cell lines, knockdown inhibits cell growth and induces apoptosis in cell lines[339] | |
| Gastric | Undetermined | Increased mRNA expression, but better patient prognosis[338] | |
| ZIP8/SLC39A8 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
| Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
| Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
| ZIP9/SLC39A9 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
| Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
| Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
| Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
| ZIP10/SLC39A10 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
| Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
| Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
| ZIP11/SLC39A11 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
| Gastric | Undetermined | Increased mRNA expression in tumors, better patient prognosis[338] | |
| Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
| Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
| ZIP12/SLC39A12 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
| Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
| ZIP13/SLC39A13 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
| Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
| Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
| ZIP14/SLC39A14 | Hepatocellular | Tumor suppressor | Decreased expression in hepatoma tissues[308,348] |
| Gastric | Undetermined | Increased mRNA expression in tumors, but better patient prognosis[338] | |
| Tumor suppressor | Decreased mRNA expression in tumors[313] | ||
| Pancreatic | Oncogene | Medium to high mRNA expression in multiple human cell lines[313] |
- Citation: Anderson KJ, Cormier RT, Scott PM. Role of ion channels in gastrointestinal cancer. World J Gastroenterol 2019; 25(38): 5732-5772
- URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5732.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5732